Sania Therapeutics launches to advance novel medicines for n

Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction Sania emerges from stealth mode and presents key proof-of-concept data at ASGCT 2023 Launching core

Related Keywords

United Kingdom , United States , London , City Of , American , Barry Ticho , Guijarro Belmar , Anna Dreismann , Mary Jane Elliott , Lucy Featherstone , Jane Hughes , Kimberly Ritola , Gewinn Nur , Andrew Murray , Martyn Goulding , Tom Otis , Rajs Dattani , Andy Murray , Consilium Strategic Communications , Salk Institute For Biological , Astrazeneca , Novartis , American Society Of Cell , American Society Of Gene Cell Therapy , University College London , Glaxosmithkline , Senior Drug Development Clinician At Weatherden , Karolinska Institute University Of Copenhagen , University Of North Carolina , Group Leader , Sania Therapeutics The Company , Sania Co , Neuroscience Center , Sainsbury Wellcome Centre For Neural Circuits , Sania Therapeutics , American Society , Cell Therapy , Series Seed , Advisory Board , Chief Executive , Formerly Group Leader , Sainsbury Wellcome Centre , Neural Circuits , Nature Neuroscience , Robert Brownstone , Science Translational , Senior Drug Development Clinician , Brain Prize , Chief Medical Officer , Board Member , Formerly Chief Scientific Officer , Gyroscope Therapeutics , Ole Kiehn , Karolinska Institute , Chief Scientific Officer , Formerly Section Head , North Carolina , Salk Institute , Senior Director , Group Lead , Gene Therapy Annual Meeting , Ligand Gated Ion Channels , Chemogenetic Modulation , Hyperexcitable Circuits , Engineering Platform , Dysfunctional Neural , Based Screening Platform , Cell Type Specific Gene Regulatory , Ysania , Herapeutics , Aunches , Advance , Novel , Medicines , Neural , Circuit , Dysfunction ,